Xcout Intel
Grifols
Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and marketing plasma-derived medicines, such as immunoglobulins, alpha-1 antitrypsin, albumin, and clotting factors, along with other innovative treatments for chronic, rare, prevalent, and life-threatening conditions. The Hospital division provides non-biological pharmaceuticals, medical supplies, clinical nutrition solutions, intravenous therapies, and medical devices. The Diagnostic division develops, manufactures, and commercializes diagnostic products that span the entire healthcare continuum, from prevention and screening to diagnosis, prognosis, and monitoring of diseases and treatments, catering to professional healthcare providers. The Bio Supplies division offers essential biological materials for life-science research, clinical trials, and the manufacturing of pharmaceutical and diagnostic products. These diverse offerings enable healthcare professionals to diagnose and treat patients suffering from conditions like hemophilia, immune deficiencies, and infectious diseases. Grifols serves a wide array of clients, including public and private healthcare organizations, wholesalers, distributors, group purchasing organizations, blood banks, hospitals, and national health systems. The company also maintains a technology collaboration agreement with Mondragon.
Subscribe to see Grifols’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Grifols at a glance
Grifols is a pharmaceuticals company headquartered in Barcelona, Spain, founded in 1909. It is publicly listed (GRFS) with a market capitalisation of $6.2B. Xcout tracks 25 named people at Grifols, including Jose Ignacio Abia Buenache (Chief Executive Officer & Director).
Grifols leadership
- Jose Ignacio Abia BuenacheChief Executive Officer & Director
- Nacho AbiaChief Executive Officer
- Lluis Pons GomezSenior Vice President of Strategy & Chief Operating Officer Office
- Rahul SrinivasanChief Financial Officer
- Camille AlpiChief Human Resources & Talent Officer
- David Ian BellChief Corporate Affairs & Legal Officer
19 more named people on record for Grifols, with roles, board committees and tenure — see the full roster →
Grifols competitors
A few of Grifols's closest competitors — see the full list of competitors and alternatives →
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a comprehensive healthcare enterprise, operating across Mainland China and international markets. Its principal activities include the research, development, production, and commercialization of pharmaceutical products. The company focuses on significant therapeutic domains such as oncology, immunology, metabolic disorders, gastrointestinal health, and central nervous system conditions. In addition to its drug offerings, Fosun Pharma provides medical devices and diagnostic solutions. Its multifaceted operations are organized into five key segments: pharmaceutical manufacturing, medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail, and other business initiatives. This scope extends to managing healthcare facilities and hospitals, as well as the wholesale and retail distribution of medicines. The company was founded in 1994 and is headquartered in Shanghai, China.
Bracco Imaging S.p.A. develops, manufactures, and markets diagnostic imaging solutions, including contrast agents and medical devices. The company serves the global healthcare industry by providing advanced imaging tools and technologies designed to improve clinical outcomes for professionals and patients.
Polpharma is a pharmaceutical company that manufactures and supplies prescription medications, over-the-counter drugs, dietary supplements, and medical devices. Operating primarily in Central and Eastern Europe, the Caucasus, and Central Asia, the company serves patients, healthcare professionals, and business partners.
Menarini is a global pharmaceutical company headquartered in Florence, Italy. It has three divisions: Menarini Ricerche, Menarini Biotech, and Menarini Diagnostics, and focuses on developing pharmacological products.
Adamed Pharma S.A. is a pharmaceutical and biotechnology company that researches, develops, and manufactures prescription drugs, over-the-counter medicines, dietary supplements, dermocosmetics, and medical devices. It serves patients across multiple therapeutic areas globally, utilizing its own scientific research and patents.
GC Biopharma is a holding company that operates through its family companies to provide biopharmaceuticals, innovative new drugs, vaccines, medical diagnostics, consumer health care products, and digital healthcare services for patients and general consumers.
Get Grifols's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Grifols in Xcout Intel
- 25 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access